Human Genetics: Pedigrees, LOD Scores, Karyotypes and Disorders
Pedigree analysis and risk calculation, LOD scores, karyotypes and ISCN notation, and chromosomal, single-gene and repeat-expansion disorders for CSIR NET.
- 19 min
On this page · 14 sections
Prerequisites
- Mendelian and Extrachromosomal Inheritance — modes of inheritance, penetrance, imprinting and mitochondrial transmission.
- Chromosomal Alterations and Recombination — non-disjunction, deletions and translocations behind the chromosomal syndromes.
- Counting, Probability and Numbers — conditional probability and Bayes’ rule for risk problems.
The Hook: Mapping a Gene Without a Single Planned Cross
Pedigree Analysis
Standard symbols
| Symbol | Meaning |
|---|---|
| Square / circle / diamond | Male / female / sex unspecified |
| Filled symbol | Affected |
| Half-filled (or dot in centre) | Heterozygous carrier (autosomal) / carrier female (X-linked, dot) |
| Diagonal line through symbol | Deceased |
| Horizontal line between two symbols | Mating; double line = consanguineous mating |
| Arrow | Proband (propositus), the person through whom the family came to attention |
| Roman numerals / Arabic numerals | Generations / individuals within a generation |
Recognising the mode of inheritance
| Mode | Key features | Examples |
|---|---|---|
| Autosomal dominant (AD) | Affected in every generation (vertical); affected person usually has an affected parent; male-to-male transmission occurs; ~½ of children of an affected heterozygote affected; both sexes equally | Huntington disease, achondroplasia, Marfan syndrome, neurofibromatosis type 1, familial hypercholesterolaemia |
| Autosomal recessive (AR) | Often skips generations (horizontal: affected siblings, unaffected parents); parents are carriers; consanguinity raises the risk; ¼ of children of two carriers affected; both sexes equally | Cystic fibrosis, sickle-cell anaemia, β-thalassaemia, phenylketonuria, Tay–Sachs disease, oculocutaneous albinism |
| X-linked recessive (XLR) | Mostly males affected; transmitted through carrier females; no male-to-male transmission; all daughters of an affected male are carriers; affected males related through females (“knight’s move”) | Haemophilia A and B, Duchenne and Becker muscular dystrophy, red–green colour blindness, G6PD deficiency |
| X-linked dominant (XLD) | Affected male passes it to all daughters and no sons; affected heterozygous female passes it to ½ of children of either sex; more affected females than males (often milder in females) | X-linked hypophosphataemic rickets; Rett syndrome (MECP2, mostly sporadic in females) |
| Y-linked | Only males, father to all sons | SRY; some Y-chromosome deletions causing azoospermia |
| Mitochondrial | Transmitted by females to all children; never by males; variable severity (heteroplasmy) | LHON, MELAS, MERRF |
A decision procedure
graph TD
A["Affected child of two
unaffected parents?"] -->|"Yes"| B["Recessive
(or reduced penetrance / new mutation)"]
A -->|"No, every affected person
has an affected parent"| C["Likely dominant"]
B --> D{"Affected females,
or affected son of
affected father?"}
D -->|"Yes"| E["Autosomal recessive"]
D -->|"Only males, through
carrier mothers"| F["X-linked recessive
(probable)"]
C --> G{"Male-to-male
transmission?"}
G -->|"Yes"| H["Autosomal dominant
(rules out X-linked)"]
G -->|"No; affected fathers have
all daughters affected,
no sons"| I["X-linked dominant"]Rules that exclude a mode outright:
- An affected daughter of an unaffected father excludes X-linked recessive (she would need his X).
- Male-to-male transmission excludes any X-linked mode.
- Two affected parents with an unaffected child exclude autosomal recessive (with full penetrance).
- An affected father passing it to a child excludes mitochondrial inheritance.
Complications that make pedigrees ambiguous
| Complication | What it does |
|---|---|
| Reduced penetrance | A dominant trait appears to skip a generation |
| Variable expressivity | Mildly affected relatives are missed |
| New (de novo) mutation | An isolated case with unaffected parents (common in achondroplasia; often linked to advanced paternal age) |
| Germline (gonadal) mosaicism | Two affected children from unaffected parents with a dominant disorder (e.g. osteogenesis imperfecta) |
| Locus heterogeneity | Mutations in different genes give the same phenotype; two deaf parents with recessive deafness can have all-hearing children if their mutations are in different genes (complementation) |
| Allelic heterogeneity | Many different mutations in one gene (CFTR); affected people are often compound heterozygotes |
| Phenocopy | An environmentally caused copy of a genetic phenotype |
| Anticipation | Earlier onset or greater severity in successive generations (repeat expansions) |
| Imprinting | Expression depends on the parent of origin |
| Uniparental disomy (UPD) | Both copies of a chromosome from one parent; can unmask a recessive allele or disrupt imprinting |
| Skewed X-inactivation | A carrier female can be a manifesting heterozygote if most active Xs carry the mutant allele |
Risk Calculation
Core probabilities
| Situation | Probability |
|---|---|
| Unaffected sibling of a person with an AR disorder (parents carriers) | 2/3 carrier (aa excluded; AA : Aa = 1 : 2) |
| Child of carrier × carrier | ¼ affected |
| Son of a carrier woman (XLR) | ½ affected |
| Daughter of an affected man (XLR) | 1 (obligate carrier) |
| Child of an affected heterozygote (AD, full penetrance) | ½ |
| Random person from a population with carrier frequency 2pq | 2pq (from Hardy–Weinberg) |
Worked example. A man whose sister has cystic fibrosis marries an unrelated woman from a population where the carrier frequency is 1/25. Risk that their first child has CF:
$$\tfrac{2}{3} \times \tfrac{1}{25} \times \tfrac{1}{4} = \tfrac{1}{150}$$Bayesian (conditional) risk
Prior probabilities are revised by conditional information (unaffected children, a normal test result, age without symptoms).
| Step | Carrier | Non-carrier |
|---|---|---|
| Prior | P | 1 − P |
| Conditional (probability of the observed data given the status) | L₁ | L₂ |
| Joint | P × L₁ | (1 − P) × L₂ |
| Posterior | joint / sum of joints | joint / sum of joints |
Example (XLR). A woman’s mother is a known carrier of Duchenne muscular dystrophy. The woman has three unaffected sons.
- Prior: carrier ½, non-carrier ½.
- Conditional: if a carrier, P(three unaffected sons) = (½)³ = 1/8; if not, 1.
- Joint: 1/16 and 1/2.
- Posterior carrier = (1/16) / (1/16 + 8/16) = 1/9.
Consanguinity
The coefficient of inbreeding (F) is the probability that two alleles at a locus in an individual are identical by descent.
| Parents | F of their child |
|---|---|
| First cousins | 1/16 |
| Uncle–niece (or half-sibs) | 1/8 |
| Siblings (or parent–child) | 1/4 |
| Second cousins | 1/64 |
Frequency of a recessive homozygote among children of an inbred mating:
$$P(aa) = q^2 (1 - F) + qF$$For a rare allele (q = 0.01), first-cousin offspring have \(0.0001 \times \tfrac{15}{16} + 0.01 \times \tfrac{1}{16} \approx 7.2 \times 10^{-4}\), about seven times the risk for unrelated parents (\(10^{-4}\)). The rarer the allele, the larger the relative effect of consanguinity, which is why affected children with very rare recessive disorders often have related parents.
Linkage in Humans: The LOD Score
To map a disease gene, geneticists follow its co-segregation with a polymorphic marker through families. Because families are small, evidence is summarised by the LOD score (logarithm of the odds), introduced by Newton Morton:
$$Z(\theta) = \log_{10} \frac{L(\text{data} \mid \theta)}{L(\text{data} \mid \theta = 0.5)}$$θ is the recombination fraction between marker and disease locus; θ = 0.5 means no linkage.
For phase-known, fully informative meioses with R recombinants out of n:
$$Z(\theta) = \log_{10} \frac{\theta^{R}(1-\theta)^{n-R}}{(0.5)^{n}}$$Worked example
Ten informative meioses, one recombinant:
| θ | 0.01 | 0.05 | 0.10 | 0.20 | 0.30 | 0.40 |
|---|---|---|---|---|---|---|
| Z(θ) | 0.97 | 1.51 | 1.60 | 1.44 | 1.09 | 0.62 |
The maximum (the maximum-likelihood estimate of θ) is at θ̂ = R/n = 0.1, with Z = 1.60.
Interpretation
| LOD | Interpretation |
|---|---|
| ≥ 3 | Significant evidence for linkage (odds 1000 : 1 in favour) |
| ≤ −2 | Linkage excluded at that θ (odds 100 : 1 against) |
| Between −2 and 3 | Inconclusive; study more families |
- LOD scores from independent families add (they are logarithms of independent likelihood ratios). Three families each giving Z = 1.60 at θ = 0.1 give 4.80: significant.
- With no recombinants in n phase-known meioses, Z(0) = n log₁₀ 2 = 0.301n, so at least 10 such meioses are needed to reach 3.
- Phase unknown (the parent’s marker–disease phase is not known): each phase is given probability ½, and Z is computed from the average likelihood, so the same data give a lower LOD.
- A significant LOD at a small θ places the gene within a few cM of the marker; the gene is then found by positional cloning (fine mapping, candidate genes, sequencing). Cystic fibrosis (CFTR, chromosome 7) is the classic success.
Karyotypes
Making a karyotype
- Cells: usually peripheral blood lymphocytes, stimulated to divide with phytohaemagglutinin (PHA); also amniocytes, chorionic villi, bone marrow or fibroblasts.
- Metaphase arrest: colchicine or colcemid (spindle inhibitors).
- Hypotonic treatment (KCl) swells the cells and spreads the chromosomes; fixation in methanol : acetic acid (3 : 1); dropping onto slides.
- Banding and staining, photography or imaging, and arrangement by size, centromere position and banding pattern.
Banding techniques
| Technique | Method | What stains |
|---|---|---|
| G-banding | Mild trypsin + Giemsa | Dark bands AT-rich, gene-poor, late-replicating; standard clinical method |
| Q-banding | Quinacrine (fluorescent) | Similar to G bands; bright distal Yq |
| R-banding | Heat denaturation + Giemsa | Reverse of G-banding (GC-rich bands dark) |
| C-banding | Alkali/heat, then Giemsa | Constitutive heterochromatin (centromeres, 1q, 9q, 16q, distal Yq) |
| NOR (silver) staining | Silver nitrate | Active nucleolar organiser regions (short arms of acrocentrics) |
The human karyotype
46 chromosomes: 22 pairs of autosomes and XX or XY. Classical groups (by size and centromere position):
| Group | Chromosomes | Description |
|---|---|---|
| A | 1–3 | Large; 1 and 3 metacentric, 2 submetacentric |
| B | 4–5 | Large submetacentric |
| C | 6–12 and X | Medium submetacentric |
| D | 13–15 | Medium acrocentric (satellites) |
| E | 16–18 | Small; 16 metacentric, 17–18 submetacentric |
| F | 19–20 | Small metacentric |
| G | 21–22 and Y | Small acrocentric (Y lacks satellites) |
Acrocentric chromosomes 13, 14, 15, 21 and 22 carry the rRNA gene clusters (NORs) on their short arms and are the ones that form Robertsonian translocations.
ISCN notation
Bands are named chromosome – arm (p short, q long) – region – band – sub-band: 7q31.2 is chromosome 7, long arm, region 3, band 1, sub-band 2.
| Karyotype | Meaning |
|---|---|
| 46,XX / 46,XY | Normal female / male |
| 47,XY,+21 | Male with trisomy 21 |
| 45,X | Turner syndrome |
| 47,XXY | Klinefelter syndrome |
| 46,XY,del(5)(p15) | Deletion of 5p15 (cri-du-chat) |
| 46,XX,t(9;22)(q34;q11) | Reciprocal translocation (Philadelphia) |
| 45,XY,der(14;21)(q10;q10) | Balanced Robertsonian carrier |
| 46,XX,inv(9)(p12q13) | Pericentric inversion of 9 |
| mos 45,X/46,XX | Mosaic |
| 46,X,i(Xq) | Isochromosome of Xq |
Molecular cytogenetics
| Method | Detects | Limitation |
|---|---|---|
| FISH | Specific sequences with fluorescent probes; microdeletions, translocations, interphase aneuploidy counts | Only what the probe targets |
| Spectral karyotyping / M-FISH | Each chromosome painted a different colour; complex rearrangements | Low resolution for small changes |
| Array CGH / SNP arrays | Genome-wide copy-number gains and losses (CNVs); SNP arrays also detect UPD and loss of heterozygosity | Cannot detect balanced translocations or inversions |
| Non-invasive prenatal testing (NIPT) | Cell-free fetal DNA in maternal plasma, counted by sequencing; screens for common trisomies | A screening test; positives are confirmed by invasive testing |
Invasive prenatal sampling uses chorionic villus sampling (earlier in pregnancy) or amniocentesis (later).
Genetic Disorders
Chromosomal disorders
| Disorder | Karyotype | Notes |
|---|---|---|
| Down syndrome | 47,+21 (most cases, free trisomy); also Robertsonian translocation and mosaic forms | Most free trisomies arise from maternal meiosis I non-disjunction; risk rises with maternal age. Translocation cases can recur in families |
| Edwards syndrome | 47,+18 | Severe; clenched hands with overlapping fingers, rocker-bottom feet |
| Patau syndrome | 47,+13 | Severe; holoprosencephaly, cleft lip/palate, polydactyly |
| Turner syndrome | 45,X (also mosaics, i(Xq)) | Female, short stature, gonadal dysgenesis, webbed neck; the only viable human monosomy |
| Klinefelter syndrome | 47,XXY | Male, tall, small testes, infertility, gynaecomastia; one Barr body |
| 47,XYY | — | Usually tall males with normal fertility |
| Triple X | 47,XXX | Usually mild; two Barr bodies |
| Cri-du-chat | 5p deletion | Cat-like cry in infancy |
| Williams syndrome | 7q11.23 microdeletion (includes elastin) | Supravalvular aortic stenosis, characteristic personality |
| DiGeorge / velocardiofacial | 22q11.2 microdeletion | Thymic and parathyroid hypoplasia, heart defects |
| Prader–Willi / Angelman | 15q11–q13 (paternal / maternal loss) | Imprinting disorders |
Single-gene disorders
| Disorder | Gene / product | Mode | Key point |
|---|---|---|---|
| Cystic fibrosis | CFTR (chloride channel), chromosome 7 | AR | Commonest mutation ΔF508 (deletion of Phe508): misfolding, ER retention |
| Sickle-cell anaemia | HBB, Glu6Val | AR | HbS polymerises when deoxygenated; carrier advantage against falciparum malaria |
| β-Thalassaemia | HBB (many mutations, often splicing or promoter) | AR | Reduced or absent β chains |
| Phenylketonuria | PAH (phenylalanine hydroxylase) | AR | Treatable by low-phenylalanine diet; newborn screening |
| Tay–Sachs disease | HEXA (hexosaminidase A) | AR | GM2 ganglioside accumulates in neurons |
| Albinism (oculocutaneous type 1) | TYR (tyrosinase) | AR | No melanin |
| Huntington disease | HTT, CAG repeat in coding region (polyglutamine) | AD | Late onset; anticipation, greater with paternal transmission |
| Achondroplasia | FGFR3, gain of function | AD | Mostly new mutations, associated with paternal age; homozygotes severely affected |
| Marfan syndrome | FBN1 (fibrillin-1) | AD | Pleiotropic connective-tissue disorder |
| Familial hypercholesterolaemia | LDLR | AD (semi-dominant) | Homozygotes far more severe |
| Neurofibromatosis type 1 | NF1 (neurofibromin, a Ras-GAP) | AD | Variable expressivity |
| Haemophilia A / B | F8 / F9 | XLR | Clotting factor VIII / IX deficiency |
| Duchenne / Becker muscular dystrophy | DMD (dystrophin) | XLR | Duchenne: usually frameshift deletions, no dystrophin; Becker: in-frame deletions, partly functional protein |
| G6PD deficiency | G6PD | XLR | Haemolysis after oxidant drugs or fava beans |
| Fragile X syndrome | FMR1, CGG repeat in 5′ UTR | X-linked | Full expansion → promoter methylation, silencing |
Repeat-expansion disorders and anticipation
| Disorder | Repeat | Location | Inheritance | Expansion bias |
|---|---|---|---|---|
| Fragile X syndrome | CGG | 5′ UTR of FMR1 | X-linked | Expansion to full mutation through mothers |
| Huntington disease | CAG | Coding (polyQ) | AD | Larger expansions through fathers |
| Myotonic dystrophy type 1 | CTG | 3′ UTR of DMPK | AD | Severe congenital form through mothers |
| Friedreich ataxia | GAA | Intron 1 of FXN | AR | Reduced frataxin |
| Spinocerebellar ataxias (several) | CAG | Coding | AD | Polyglutamine |
Fragile X shows the Sherman paradox: the risk of being affected depends on the position in the pedigree, because a premutation (an intermediate repeat length, without the syndrome) can expand to a full mutation when passed through a female. Normal males can carry a premutation (“normal transmitting males”) and pass it to all their daughters without expansion to a full mutation.
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| X-linked recessive: affected father → all daughters carriers, no affected sons | vs | X-linked dominant: affected father → all daughters affected, no sons |
| Mitochondrial: mother → all children | vs | XLR: carrier mother → half her sons |
| Locus heterogeneity (different genes) | vs | Allelic heterogeneity (different alleles of one gene) |
| Linkage (co-segregation in families) | vs | Association (allele frequency in cases vs controls) |
| LOD ≥ 3 (linkage) | vs | LOD ≤ −2 (exclusion) |
| G-banding (dark = AT-rich) | vs | R-banding (reverse) |
| Array CGH (copy number) | vs | Karyotype/FISH (also balanced rearrangements) |
| Duchenne (frameshift; no dystrophin) | vs | Becker (in-frame; reduced dystrophin) |
| Klinefelter 47,XXY male | vs | Turner 45,X female |
| Premutation (no syndrome, unstable) | vs | Full mutation (silenced FMR1) |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- What karyotype notation describes a male with Klinefelter syndrome?
- Which observation in a pedigree rules out X-linked inheritance?
- What LOD score is conventionally taken as significant evidence for linkage?
Answers
- 47,XXY.
- Male-to-male transmission (a father gives his son a Y, not an X).
- 3 (odds of 1000 : 1).
Level 2: Part B Style
Q1 (practice). In a pedigree, a rare trait appears in three generations. Every affected man has all daughters affected and all sons unaffected; affected women have affected sons and daughters in roughly equal numbers. The most likely mode is:
- (a) Autosomal dominant
- (b) X-linked recessive
- (c) X-linked dominant
- (d) Mitochondrial
Answer and explanation
(c). An affected father transmits his X to every daughter and never to a son. Mitochondrial inheritance would give no transmission at all from affected men; autosomal dominant would give affected sons from affected fathers.
Q2 (practice). Which karyotyping method would fail to detect a balanced reciprocal translocation?
- (a) G-banded karyotype
- (b) Spectral karyotyping
- (c) Array comparative genomic hybridisation
- (d) FISH with probes spanning the breakpoints
Answer and explanation
(c). Array CGH measures copy number; a balanced translocation has no net gain or loss.
Q3 (practice). Two first cousins marry. Their common grandfather was a known heterozygous carrier of a rare autosomal recessive allele; assume no other source of the allele in the family. The probability that their first child is affected is:
- (a) 1/16
- (b) 1/64
- (c) 1/256
- (d) 1/4
Answer and explanation
(b) 1/64. Each cousin is two transmissions from the grandfather (grandfather → parent ½, parent → cousin ½), so each is a carrier with probability 1/4. Child affected = 1/4 × 1/4 × 1/4 (both carriers, then aa) = 1/64. The trap (a) is the coefficient of inbreeding F = 1/16, which is the probability that the child is homozygous by descent for some grandparental allele, not for this specific allele (only one of the four grandparental alleles is the mutant one: 1/16 × 1/4 = 1/64 again).
Q4 (practice). A child with trisomy 21 has, at a marker tightly linked to the chromosome 21 centromere, two identical maternal alleles and one paternal allele. The mother is heterozygous at that marker. The error most likely occurred in:
- (a) maternal meiosis I
- (b) maternal meiosis II
- (c) paternal meiosis I
- (d) a post-zygotic mitosis in the father’s chromosome
Answer and explanation
(b). Two identical copies of one maternal centromeric allele means sister chromatids failed to separate: maternal meiosis II. A meiosis I error would give both of the mother’s different alleles.
Level 3: Part C Style
Q1 (practice). Three unrelated families segregating an autosomal dominant disease are typed for a marker. In each family there are 10 phase-known, fully informative meioses with exactly one recombinant.
(i) Calculate Z(θ) for one family at θ = 0.1 and θ = 0.2. (ii) What is the combined LOD at θ = 0.1, and what do you conclude? (iii) What is the minimum number of phase-known meioses with no recombinants needed to reach LOD 3 in a single family?
Answer and worked solution
(i) \(Z(0.1) = \log_{10}\dfrac{0.1 \times 0.9^{9}}{0.5^{10}} = \log_{10}\dfrac{0.03874}{9.766\times10^{-4}} = \log_{10} 39.67 = 1.60\). \(Z(0.2) = \log_{10}\dfrac{0.2 \times 0.8^{9}}{0.5^{10}} = \log_{10} 27.49 = 1.44\).
(ii) LODs add: 3 × 1.598 = 4.80 at θ = 0.1 (the maximum, since θ̂ = 3/30 = 0.1). This exceeds 3: significant linkage, with the gene about 10 cM from the marker.
(iii) \(Z(0) = n \log_{10} 2 = 0.301n \ge 3\) → n ≥ 9.97 → 10 meioses.
Q2 (practice). A woman’s mother is a proven carrier of haemophilia A. The woman herself has three unaffected sons. Which statements are correct?
(P) Before considering her sons, her probability of being a carrier is 1/2. (Q) After considering her three unaffected sons, her probability of being a carrier is 1/9. (R) The probability that her next son will be affected is 1/18. (S) Her daughters cannot be carriers, because her sons are unaffected.
- (a) P, Q and R
- (b) P and Q only
- (c) Q and S only
- (d) P, Q, R and S
Answer and worked solution
(a) P, Q and R.
| Carrier | Not a carrier | |
|---|---|---|
| Prior | 1/2 | 1/2 |
| P(3 unaffected sons) | (1/2)³ = 1/8 | 1 |
| Joint | 1/16 | 8/16 |
| Posterior | 1/9 | 8/9 |
(R) P(next son affected) = 1/9 × 1/2 = 1/18. (S) is wrong: unaffected sons lower her probability of being a carrier but do not make it zero; daughters could still inherit a mutant X.
Q3 (practice). A man has a sister with cystic fibrosis; neither parent is affected. He marries an unrelated woman from a population in which CF affects 1 in 2,500 births. Calculate the risk that their first child has CF.
Answer and worked solution
- Man: unaffected sibling of an affected person → carrier probability 2/3.
- Woman: q² = 1/2500 → q = 0.02, p = 0.98, carrier frequency 2pq = 0.0392 ≈ 1/25.
- Risk = 2/3 × 1/25 × 1/4 = 1/150 (≈ 0.0067). Using the exact 0.0392 gives 0.0065.
If they then have an affected child, both are proven carriers and the risk for each later child rises to 1/4: data from children update the parents’ genotypes.
Quick Revision Table
| Item | Fact |
|---|---|
| AD | Every generation; male-to-male; ½ risk; Huntington, achondroplasia, Marfan, NF1, FH |
| AR | Skips; consanguinity; ¼ risk; unaffected sib 2/3 carrier; CF, sickle cell, PKU, Tay–Sachs |
| XLR | Males; carrier mothers; no male-to-male; haemophilia, DMD, colour blindness, G6PD |
| XLD | Affected father → all daughters; hypophosphataemic rickets, Rett |
| Y-linked / mito | Father → all sons / mother → all children |
| Exclusions | Affected daughter of unaffected father ≠ XLR; male-to-male ≠ X-linked; affected parents with unaffected child ≠ AR |
| Bayes | Prior × conditional → joint → normalise |
| F | First cousins 1/16; P(aa) = q²(1 − F) + qF |
| LOD | \(\log_{10}[L(\theta)/L(0.5)]\); ≥ 3 linkage, ≤ −2 exclusion; families add; 0 recombinants → 0.301n |
| Karyotype prep | PHA, colchicine, hypotonic KCl, methanol : acetic acid 3 : 1 |
| Banding | G (Giemsa, trypsin), Q (quinacrine), R (reverse), C (heterochromatin), NOR (silver) |
| Acrocentrics | 13, 14, 15, 21, 22 (+ Y) |
| ISCN | 47,XY,+21; 45,X; del(5)(p15); t(9;22)(q34;q11); der(14;21)(q10;q10) |
| Array CGH | Copy number only; misses balanced rearrangements |
| Chromosomal syndromes | Down +21, Edwards +18, Patau +13, Turner 45,X, Klinefelter 47,XXY |
| Microdeletions | 5p (cri-du-chat), 7q11.23 (Williams), 22q11.2 (DiGeorge), 15q11–q13 (PWS/AS) |
| Repeats | CGG fragile X (5′ UTR), CAG Huntington (coding), CTG DM1 (3′ UTR), GAA Friedreich (intron, AR) |
| Anticipation bias | HD paternal; fragile X and congenital DM1 maternal |
Key Takeaways
What’s Next
- Quantitative and Population Genetics — Hardy–Weinberg carrier frequencies, heritability and association mapping of complex traits.
- Chromosomal Alterations and Recombination — revisit non-disjunction and translocation segregation.
- Regulation of Gene Expression and Epigenetics — X-inactivation, imprinting and FMR1 silencing at the molecular level.
- Inheritance Biology — Quick Revision — the unit on one page.